Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects
Medical Science Monitor · 2024
DOI: 10.12659/msm.945211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Xiaotong Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Cachexia, Tripartite Motif Proteins, Ubiquitin-Protein Ligases, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Yanmei Lu
Zitieren
APA
Liu, X., Wen, Y., & Lu, Y. (2024). Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects. Medical Science Monitor. https://doi.org/10.12659/msm.945211
Vancouver
Liu X, Wen Y, Lu Y. Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects. Medical Science Monitor. 2024. doi:10.12659/msm.945211
BibTeX
@article{Liu2024,
author = {Liu, Xiaotong and Wen, Ya and Lu, Yanmei},
title = {Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects},
journal = {Medical Science Monitor},
year = {2024},
doi = {10.12659/msm.945211}
}
EUVIMED